Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
Journal of Gastroenterology and Hepatology|October 23, 2018
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitisEmma L Culver, Fleur S van de Bovenkamp, Ninotska I L Derksen, et al.
Journal of Virology|September 11, 2009
Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infectionIsla Humphreys, Vicki Fleming, Paolo Fabris, et al.
Hepatology Communications|September 12, 2021
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019Tingyan Wang, David A Smith, Cori Campbell, et al.
Hepatology Communications|October 28, 2021
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 VaccinationAndrew M Moon, Gwilym J Webb, Ignacio García-Juárez, et al.
Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.
Gastroenterology|August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infectionGraham R Foster, Stephen Pianko, Ashley Brown, et al.
Frontiers in Microbiology|November 9, 2020
Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical PathwayCarmen F Manso, David F Bibby, Kieren Lythgow, et al.
Journal of Hepatology|January 28, 2021
SARS-CoV-2 infection in patients with autoimmune hepatitisThomas Marjot, Gustav Buescher, Marcial Sebode, et al.
NPJ Vaccines|September 29, 2021
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccinationElena Woods, Vanessa Zaiatz-Bittencourt, Ciaran Bannan, et al.
BMC Infectious Diseases|June 27, 2021
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort studyTingyan Wang, David A Smith, Cori Campbell, et al.
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
Journal of Gastroenterology and Hepatology|October 23, 2018
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitisEmma L Culver, Fleur S van de Bovenkamp, Ninotska I L Derksen, et al.
Journal of Virology|September 11, 2009
Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infectionIsla Humphreys, Vicki Fleming, Paolo Fabris, et al.
Hepatology Communications|September 12, 2021
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019Tingyan Wang, David A Smith, Cori Campbell, et al.
Hepatology Communications|October 28, 2021
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 VaccinationAndrew M Moon, Gwilym J Webb, Ignacio García-Juárez, et al.
Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.
Gastroenterology|August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infectionGraham R Foster, Stephen Pianko, Ashley Brown, et al.
Frontiers in Microbiology|November 9, 2020
Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical PathwayCarmen F Manso, David F Bibby, Kieren Lythgow, et al.
Journal of Hepatology|January 28, 2021
SARS-CoV-2 infection in patients with autoimmune hepatitisThomas Marjot, Gustav Buescher, Marcial Sebode, et al.
NPJ Vaccines|September 29, 2021
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccinationElena Woods, Vanessa Zaiatz-Bittencourt, Ciaran Bannan, et al.
BMC Infectious Diseases|June 27, 2021
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort studyTingyan Wang, David A Smith, Cori Campbell, et al.
Pageof 23